US 7659278
Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
granted A61KA61K31/4015A61K31/439
Quick answer
US patent 7659278 (Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases) held by APREA AB expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- APREA AB
- Grant date
- Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/4015, A61K31/439, A61K31/4745, A61K31/519